194 related articles for article (PubMed ID: 17612054)
21. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
Townsend KP; Praticò D
FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
[TBL] [Abstract][Full Text] [Related]
22. [The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs].
de Jong D; Jansen RW; Verbeek MM; Kremer HP
Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2074-8. PubMed ID: 12448960
[TBL] [Abstract][Full Text] [Related]
23. Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.
Sastre M; Klockgether T; Heneka MT
Int J Dev Neurosci; 2006; 24(2-3):167-76. PubMed ID: 16472958
[TBL] [Abstract][Full Text] [Related]
24. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.
Weggen S; Eriksen JL; Das P; Sagi SA; Wang R; Pietrzik CU; Findlay KA; Smith TE; Murphy MP; Bulter T; Kang DE; Marquez-Sterling N; Golde TE; Koo EH
Nature; 2001 Nov; 414(6860):212-6. PubMed ID: 11700559
[TBL] [Abstract][Full Text] [Related]
25. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study.
Andersen K; Launer LJ; Ott A; Hoes AW; Breteler MM; Hofman A
Neurology; 1995 Aug; 45(8):1441-5. PubMed ID: 7644037
[TBL] [Abstract][Full Text] [Related]
26. Is it All Said for NSAIDs in Alzheimer's Disease? Role of Mitochondrial Calcium Uptake.
Sanz-Blasco S; Calvo-Rodriguez M; Caballero E; Garcia-Durillo M; Nunez L; Villalobos C
Curr Alzheimer Res; 2018; 15(6):504-510. PubMed ID: 29283047
[TBL] [Abstract][Full Text] [Related]
27. Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.
Blasko I; Grubeck-Loebenstein B
Drugs Aging; 2003; 20(2):101-13. PubMed ID: 12534311
[TBL] [Abstract][Full Text] [Related]
28. NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer's disease: an investigation by docking, molecular dynamics, and DFT studies.
Azam F; Alabdullah NH; Ehmedat HM; Abulifa AR; Taban I; Upadhyayula S
J Biomol Struct Dyn; 2018 Jun; 36(8):2099-2117. PubMed ID: 28571516
[TBL] [Abstract][Full Text] [Related]
29. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.
Hoozemans JJ; Veerhuis R; Rozemuller JM; Eikelenboom P
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):57-67. PubMed ID: 21143138
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs.
McGeer PL; Guo JP; Lee M; Kennedy K; McGeer EG
J Alzheimers Dis; 2018; 62(3):1219-1222. PubMed ID: 29103042
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
Halliday G; Robinson SR; Shepherd C; Kril J
Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
[TBL] [Abstract][Full Text] [Related]
32. Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence.
Szekely CA; Zandi PP
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):132-9. PubMed ID: 20205647
[TBL] [Abstract][Full Text] [Related]
33. [Cyclooxygenases, lipoxygenases, their targeted drugs and the prevention of Alzheimer's disease].
Shen JN; Xu LX; Wang R
Yao Xue Xue Bao; 2013 Dec; 48(12):1743-54. PubMed ID: 24689230
[TBL] [Abstract][Full Text] [Related]
34. Vaccines for Alzheimer's disease: how close are we?
Janus C
CNS Drugs; 2003; 17(7):457-74. PubMed ID: 12751917
[TBL] [Abstract][Full Text] [Related]
35. [Recent development of non-steroidal anti-inflammatory drugs on the neuro-inflammation of Alzheimer's disease].
Ma XW; Li JZ; Zhang TT; Du GH
Yao Xue Xue Bao; 2014 Sep; 49(9):1211-7. PubMed ID: 25518320
[TBL] [Abstract][Full Text] [Related]
36. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease.
Ozben T; Ozben S
Clin Biochem; 2019 Oct; 72():87-89. PubMed ID: 30954437
[TBL] [Abstract][Full Text] [Related]
37. Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease.
Chen CH; Zhou W; Liu S; Deng Y; Cai F; Tone M; Tone Y; Tong Y; Song W
Int J Neuropsychopharmacol; 2012 Feb; 15(1):77-90. PubMed ID: 21329555
[TBL] [Abstract][Full Text] [Related]
38. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo.
Eriksen JL; Sagi SA; Smith TE; Weggen S; Das P; McLendon DC; Ozols VV; Jessing KW; Zavitz KH; Koo EH; Golde TE
J Clin Invest; 2003 Aug; 112(3):440-9. PubMed ID: 12897211
[TBL] [Abstract][Full Text] [Related]
39. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.
McGeer PL; McGeer EG
Acta Neuropathol; 2013 Oct; 126(4):479-97. PubMed ID: 24052108
[TBL] [Abstract][Full Text] [Related]
40. Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?
Ho L; Qin W; Stetka BS; Pasinetti GM
CNS Drugs; 2006; 20(2):85-98. PubMed ID: 16478285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
